Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.2503
-0.1797 (-41.79%)
At close: Aug 20, 2026
Biomind Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0 | 0 | 0.02 | 0.03 | 2.27 |
Cash & Short-Term Investments | 0 | 0 | 0 | 0.02 | 0.03 | 2.27 |
Cash Growth | -87.27% | -75.51% | -99.39% | -7.23% | -98.85% | - |
Prepaid Expenses | - | - | - | - | 0.02 | 0.17 |
Other Current Assets | - | - | 0.02 | 0.02 | - | - |
Total Current Assets | 0 | 0 | 0.02 | 0.05 | 0.04 | 2.44 |
Property, Plant & Equipment | - | - | 0.02 | 0.03 | 0.04 | 0.09 |
Total Assets | 0 | 0 | 0.04 | 0.07 | 0.09 | 2.53 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.32 | 0.39 | 0.27 | 0.56 | 0.33 | 0.29 |
Accrued Expenses | 0.48 | - | - | - | - | - |
Short-Term Debt | 0.83 | 0.73 | 0.67 | 0.74 | - | - |
Current Portion of Leases | - | - | - | - | 0.01 | 0.04 |
Other Current Liabilities | 0.28 | 0.62 | 0.4 | 0.21 | - | - |
Total Current Liabilities | 1.9 | 1.74 | 1.34 | 1.51 | 0.34 | 0.32 |
Long-Term Leases | - | - | - | - | - | 0.01 |
Total Liabilities | 1.9 | 1.74 | 1.34 | 1.51 | 0.34 | 0.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 11.45 | 11.45 | 11.45 | 11.1 | 11.1 | 11.1 |
Retained Earnings | -16.52 | -15.74 | -14.88 | -14.62 | -13.43 | -10.45 |
Comprehensive Income & Other | 3.17 | 2.55 | 2.14 | 2.09 | 2.08 | 1.54 |
Shareholders' Equity | -1.9 | -1.74 | -1.3 | -1.43 | -0.25 | 2.19 |
Total Liabilities & Equity | 0 | 0 | 0.04 | 0.07 | 0.09 | 2.53 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.83 | 0.73 | 0.67 | 0.74 | 0.01 | 0.05 |
Net Cash (Debt) | -0.83 | -0.73 | -0.67 | -0.72 | 0.02 | 2.23 |
Net Cash Growth | - | - | - | - | -99.19% | - |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.03 |
Filing Date Shares Outstanding | 77.57 | 77.57 | 77.57 | 74.76 | 74.76 | 74.76 |
Total Common Shares Outstanding | 77.57 | 77.57 | 77.57 | 74.76 | 74.76 | 74.76 |
Working Capital | -1.9 | -1.74 | -1.32 | -1.46 | -0.29 | 2.11 |
Book Value Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.00 | 0.03 |
Tangible Book Value | -1.9 | -1.74 | -1.3 | -1.43 | -0.25 | 2.19 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.00 | 0.03 |
Machinery | - | - | 0.04 | 0.04 | 0.04 | 0.04 |